Sphingolipidomics in Translational Sepsis Research-Biomedical Considerations and Perspectives.

Claus RA, Graeler MH

Open source

DOI
10.3389/fmed.2020.616578
Published
2020
Container
Frontiers in medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fmed.2020.616578,
  title = {Sphingolipidomics in Translational Sepsis Research-Biomedical Considerations and Perspectives.},
  author = {Claus RA and Graeler MH},
  year = {2020},
  journal = {Frontiers in medicine},
  doi = {10.3389/fmed.2020.616578},
  url = {https://doi.org/10.3389/fmed.2020.616578}
}

RIS

TY  - JOUR
TI  - Sphingolipidomics in Translational Sepsis Research-Biomedical Considerations and Perspectives.
AU  - Claus RA
AU  - Graeler MH
PY  - 2020
JO  - Frontiers in medicine
DO  - 10.3389/fmed.2020.616578
UR  - https://doi.org/10.3389/fmed.2020.616578
ER  - 

APA

RA, C., & MH, G. (2020). Sphingolipidomics in Translational Sepsis Research-Biomedical Considerations and Perspectives.. Frontiers in medicine. https://doi.org/10.3389/fmed.2020.616578

Source records